Goeman Jelle J, Oosting Jan, Cleton-Jansen Anne-Marie, Anninga Jakob K, van Houwelingen Hans C
Department of Medical Statistics, Leiden University Medical Center, The Netherlands.
Bioinformatics. 2005 May 1;21(9):1950-7. doi: 10.1093/bioinformatics/bti267. Epub 2005 Jan 18.
A recent surge of interest in survival as the primary clinical endpoint of microarray studies has called for an extension of the Global Test methodology to survival.
We present a score test for association of the expression profile of one or more groups of genes with a (possibly censored) survival time. Groups of genes may be pathways, areas of the genome, clusters from a cluster analysis or all genes on a chip. The test allows one to test hypotheses about the influence of these groups of genes on survival directly, without the intermediary of single gene testing. The test is based on the Cox proportional hazards model and is calculated using martingale residuals. It is possible to adjust the test for the presence of covariates. We also present a diagnostic graph to assist in the interpretation of the test result, visualizing the influence of genes. The test is applied to a tumor dataset, revealing pathways from the gene ontology database that are associated with survival of patients.
The Global Test for survival has been incorporated into the R-package globaltest (version 3.0), available at http://www.bioconductor.org
最近,人们对将生存作为微阵列研究的主要临床终点的兴趣激增,这就要求将全局检验方法扩展到生存分析。
我们提出了一种用于检验一组或多组基因的表达谱与(可能被删失的)生存时间之间关联的计分检验。基因组可以是通路、基因组区域、聚类分析中的聚类或芯片上的所有基因。该检验允许直接检验这些基因组对生存的影响的假设,而无需进行单基因检验。该检验基于Cox比例风险模型,并使用鞅残差进行计算。可以针对协变量的存在对检验进行调整。我们还提出了一种诊断图,以帮助解释检验结果,直观显示基因的影响。该检验应用于一个肿瘤数据集,揭示了基因本体数据库中与患者生存相关的通路。
生存全局检验已被纳入R包globaltest(版本3.0),可从http://www.bioconductor.org获取